AptarGroup Inc.
ATR | NYSE
$137.20
+$6.56 (+5.02%)
At close: Oct 30, 2026, 4:00 PM ET
$137.25
+$0.05 (+0.04%)
Pre-market:
Nov 2, 2026, 5:34 AM ET
Company Profile
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
Key Executives
| Name | Position |
|---|---|
| Gael Touya | CEO, President & Director |
| Irene Hudson | Executive Vice President, Chief Legal Officer & Corporate Secretary |
| Vanessa Kanu | Executive Vice President & Chief Financial Officer |
| Aditya J. Gandhi | VP, Principal Accounting Officer & Chief Accounting Officer |
| Alex Theodorakis | Head of Pharma Prescription |
| Daniel Richard Ackerman | Senior VP, Interim Chief Accounting Officer & Principal Accounting Officer |
| Hedi Tlili | President of Aptar Closures |
| Marc Prieur | President of Aptar Beauty |
| Mary Skafidas | Senior Vice President of Investor Relations & Communications |
| Shiela Pallerne Vinczeller | Chief Human Resources Officer |
| Stephan Tanda | Director & Advisor |
| Xiangwei Gong | Executive VP of Strategic Group Development & President of Aptar Asia |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 21, 2026 | 8-K | Current Report |
| Sep 11, 2026 | 3 | Filing |
| Sep 10, 2026 | 8-K | Current Report |
| Sep 03, 2026 | 4 | Filing |
| Sep 02, 2026 | 4 | Filing |
| Sep 01, 2026 | 8-K | Current Report |
| Aug 28, 2026 | 4 | Filing |
| Aug 12, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 05, 2026 | 4 | Filing |
| Aug 04, 2026 | 4 | Filing |
AptarGroup Inc.
| Country | United States |
| IPO Date | Apr 23, 1993 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 14,000 |
| CEO | Gael Touya |
Contact Details
265 Exchange Drive Crystal Lake,
Illinois 60014 United States
Stock Details
| Ticker Symbol | ATR |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000896622 |
| CUSIP Number | 038336103 |
| ISIN Number | US0383361039 |
| SIC Code | 3089 |
Recent News
- 6 hours ago / prnewswire.comAtrium Therapeutics to Present Nonclinical Data Showing ATR 1072 Reversed and Improved Features of PRKAG2 Syndrome During HCMS at AHA Scientific Sessions 2026
- 2 days ago / seekingalpha.comAptarGroup, Inc. (ATR) Q3 2026 Earnings Call Transcript
- 2 days ago / marketbeat.comWhat AptarGroup (ATR) Said on Its Q3 Earnings Call
- 3 days ago / zacks.comAptarGroup (ATR) Q3 Earnings and Revenues Beat Estimates
- 5 days ago / globenewswire.comRakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program
- 28 days ago / zacks.comAptarGroup (ATR) Loses 5.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- 1 month ago / zacks.com3 Packaging Stocks Worth Watching Despite Industry Pressure
- 2 months ago / seekingalpha.comAptarGroup, Inc. (ATR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- 2 months ago / seekingalpha.comAptarGroup, Inc. (ATR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
- 2 months ago / prnewswire.comCytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings
Add to Watchlist
Select watchlists to add or remove ATR